eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | melanoma, malignant |
| Symptom | C0037274|skin disease |
| Sentences | 1 |
| PubMedID- 22397594 | Ipilimumab, marketed as yervoy® by bristol-myers squibb, is the first therapeutic agent which increases survival time in patients with metastatic malignant melanoma, the leading cause of death from skin disease . |
Page: 1